An increasing body of evidence suggests a fundamental role of oxidative stress in promoting and aggravating endothelial dysfunction and cardiovascular disease as a result of the inhibition of endothelial nitric oxide synthase (eNOS) enzyme activity and reduced nitric oxide (NO) production and availability [33,34]. This evidence concerns the gene NOS3 and endothelial dysfunction.